124 related articles for article (PubMed ID: 7591025)
21. Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats.
Okada H; Suzuki H; Kanno Y; Saruta T
J Cardiovasc Pharmacol; 1995 May; 25(5):847-52. PubMed ID: 7630164
[TBL] [Abstract][Full Text] [Related]
22. ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time.
Brown NJ; Kumar S; Painter CA; Vaughan DE
Hypertension; 2002 Dec; 40(6):859-65. PubMed ID: 12468570
[TBL] [Abstract][Full Text] [Related]
23. Effects of OPC-21268, a vasopressin V1-receptor antagonist, on expression of growth factors from glomeruli in spontaneously hypertensive rats.
Otsuka F; Ogura T; Yamauchi T; Oishi T; Hashimoto M; Mimura Y; Makino H
Regul Pept; 1997 Oct; 72(2-3):87-95. PubMed ID: 9652981
[TBL] [Abstract][Full Text] [Related]
24. Are sodium-dependent V1 receptors and sympathetic nerve activations involved in regulation of blood pressure in borderline-hypertensive Hiroshima rats?
Teranishi Y; Kumazaki T; Miho N; Sugino H; Tsuru H
Hypertens Res; 2002 Sep; 25(5):763-71. PubMed ID: 12452331
[TBL] [Abstract][Full Text] [Related]
25. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
Mervaala EM; Malmberg L; Teräväinen TL; Laakso J; Vapaatalo H; Karppanen H
Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
[TBL] [Abstract][Full Text] [Related]
26. Ramipril therapy improves arterial dilation in experimental hypertension.
Hutri-Kähönen N; Kähönen M; Tolvanen JP; Wu X; Sallinen K; Pörsti I
Cardiovasc Res; 1997 Jan; 33(1):188-95. PubMed ID: 9059543
[TBL] [Abstract][Full Text] [Related]
27. Late treatment with ramipril increases survival in old spontaneously hypertensive rats.
Linz W; Wohlfart P; Schoelkens BA; Becker RH; Malinski T; Wiemer G
Hypertension; 1999 Aug; 34(2):291-5. PubMed ID: 10454456
[TBL] [Abstract][Full Text] [Related]
28. Renal medulla and bradykinin during the development of hypertension in SHR.
O'Sullivan JB; Bertram JF; Harrap SB
Clin Exp Pharmacol Physiol; 1995; 22(6-7):463-5. PubMed ID: 8582104
[TBL] [Abstract][Full Text] [Related]
29. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
[TBL] [Abstract][Full Text] [Related]
30. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
31. Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the rat.
Fraser TB; Turner SW; Wen C; Li M; Burrell LM; Whitworth JA
Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):866-70. PubMed ID: 11071300
[TBL] [Abstract][Full Text] [Related]
32. Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertension.
Burrell LM; Risvanis J; Phillips PA; Naitoh M; Johnston CI
Clin Exp Hypertens; 1997; 19(5-6):981-91. PubMed ID: 9247769
[TBL] [Abstract][Full Text] [Related]
33. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
Becker RH; Baldes L; Treudler M
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S35-9. PubMed ID: 2474099
[TBL] [Abstract][Full Text] [Related]
34. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
35. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.
Linz W; Gohlke P; Unger T; Schölkens BA
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309
[TBL] [Abstract][Full Text] [Related]
36. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145
[TBL] [Abstract][Full Text] [Related]
37. Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.
Yamauchi T; Ogura T; Oishi T; Harada K; Hashimoto M; Mimura Y; Asano N; Ota Z; Kageyama J
Acta Med Okayama; 1995 Feb; 49(1):53-9. PubMed ID: 7762410
[TBL] [Abstract][Full Text] [Related]
38. Contribution of endogenous vasopressin to regional hemodynamics in borderline-hypertensive Hiroshima rats.
Teranishi Y; Sugino H; Ozono R; Ishioka N; Kumazaki T; Tsuru H
Hypertens Res; 2002 Mar; 25(2):241-8. PubMed ID: 12047040
[TBL] [Abstract][Full Text] [Related]
39. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
